PubMed COVID-19 Clinical Care

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study

Thursday, January 04, 2024 - 4:00 AM

Oral nirmatrelvir/ritonavir is approved as treatment for acute COVID-19, but the effect of treatment during acute infection on risk of Long COVID is unknown. We hypothesized that nirmatrelvir treatment during acute SARS-CoV-2 infection reduces risk

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations

Thursday, January 04, 2024 - 4:00 AM

CONCLUSIONS: This study highlights the dynamics of IgG responses dependent on vaccine type and number of doses, leading to immunological tolerance and IgG4 induction, and shaping future vaccination strategies.

A virtual intergenerational befriending intervention reduces Social Isolation in Older Adults and improves students' attitude towards companionship: A Qualitative Study

Thursday, January 04, 2024 - 4:00 AM

CONCLUSIONS: The virtual intergenerational intervention to befriending reduced boredom and loneliness in older adults and enhanced positive attitude and confidence in university students. Students helped older adults to develop digital skills on the

AKI in Adults with COVID-19 Infection: Mechanisms of Development and Role of Blood Filtration Devices in Treatment

Thursday, January 04, 2024 - 4:00 AM

During the coronavirus disease 2019 (COVID-19) pandemic, acute kidney injury (AKI) was a common sequela of COVID-19 infection and predicted disease severity and mortality. Extracorporeal blood purification techniques involving blood filtration

Acupuncture for sudden sensorineural hearing loss after COVID-19: a case report

Thursday, January 04, 2024 - 4:00 AM

No abstract